High Growth Tech Stocks To Watch In February 2026

Simply Wall St

Wed, February 18, 2026 at 6:38 PM GMT+9 4 min read

In this article:

GNMSF

-3.49%

DCBO

-0.79%

2368.TW

-2.01%

^IXIC

+0.14%

002558.SZ

-0.78%

As global markets navigate a landscape marked by AI disruption concerns and robust U.S. job gains, major indices like the Nasdaq Composite have experienced notable declines, reflecting broader market sentiment. Amidst this backdrop, identifying high growth tech stocks involves looking for companies that demonstrate resilience and adaptability to technological shifts while maintaining strong fundamentals in an evolving economic environment.

Top 10 High Growth Tech Companies Globally

Click here to see the full list of 215 stocks from our Global High Growth Tech and AI Stocks screener.

Here’s a peek at a few of the choices from the screener.

Genmab

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Genmab A/S is a biotechnology company that focuses on developing antibody-based products for cancer and other diseases in Denmark, with a market cap of DKK120.33 billion.

Operations: The company generates revenue primarily from its biotechnology segment, amounting to $3.85 billion.

Genmab’s recent financial performance reflects a nuanced trajectory in the high-growth tech landscape, particularly within biotechnology innovations. In 2025, the company reported a revenue increase to $3.72 billion from $3.12 billion in the previous year, though net income slightly decreased from $1.13 billion to $963 million. Looking ahead to 2026, Genmab anticipates revenue between $4.1 and $4.4 billion, driven by escalating royalties and sales from key therapies like DARZALEX and Kesimpta. This projection aligns with their strategic emphasis on R&D expenditure which consistently fuels their pipeline development—critical for maintaining momentum in a competitive sector where innovation leads market dynamics.

Navigate through the intricacies of Genmab with our comprehensive health report here.

Examine Genmab's past performance report to understand how it has performed in the past.

CPSE:GMAB Earnings and Revenue Growth as at Feb 2026

Sensirion Holding

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Sensirion Holding AG is involved in the development, production, sale, and servicing of sensor systems, modules, and components across various regions including Asia Pacific, Europe, the Middle East, Africa, and the Americas with a market capitalization of CHF903.62 million.

Story Continues  

Operations: Sensirion Holding AG generates revenue primarily through its sensor systems, modules, and components segment, amounting to CHF333.08 million. The company operates across multiple regions including Asia Pacific, Europe, the Middle East, Africa, and the Americas.

Sensirion Holding AG has demonstrated a robust trajectory in the tech sector, notably with its latest sensor innovations. In 2026, the company introduced the SCD53 CO2 sensor, distinguished by its long-term stability and independence from traditional recalibration methods. This launch aligns with Sensirion’s commitment to R&D, which is evident from their consistent investment in research; last year alone, R&D expenses accounted for a significant portion of their revenue. These strategic moves not only enhance Sensirion’s product offerings but also position it advantageously within environmental monitoring technologies—a field increasingly critical as industries seek sustainable solutions. Their participation at India Energy Week further underscores their proactive approach in expanding market reach and adapting to diverse industrial needs.

Click to explore a detailed breakdown of our findings in Sensirion Holding's health report.

Evaluate Sensirion Holding's historical performance by accessing our past performance report.

SWX:SENS Revenue and Expenses Breakdown as at Feb 2026

Docebo

Simply Wall St Growth Rating: ★★★★★☆

Overview: Docebo Inc. develops and provides a learning management platform for training in North America and internationally, with a market cap of CA$735.04 million.

Operations: The company generates revenue primarily through its educational software segment, amounting to CA$236.69 million.

Docebo’s strategic maneuvers in the tech sector are underscored by its robust revenue forecast, projecting an increase to between USD 267.5 million and USD 269.5 million by year-end 2026, marking a growth of approximately 10.3% annually. This is complemented by an aggressive share repurchase program, where up to 2.94 million shares will be bought back, signaling strong confidence in its financial health and future prospects. Additionally, the company’s earnings are expected to surge at a rate of 29.3% per year, outpacing the Canadian market average significantly and reflecting both operational efficiency and a deep commitment to innovation—a crucial driver in maintaining competitive edge within the fast-evolving software industry.

Take a closer look at Docebo's potential here in our health report.

Review our historical performance report to gain insights into Docebo's's past performance.

TSX:DCBO Earnings and Revenue Growth as at Feb 2026

Next Steps

Access the full spectrum of 215 Global High Growth Tech and AI Stocks by clicking on this link.

Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.

Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Interested In Other Possibilities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

Find companies with promising cash flow potential yet trading below their fair value.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include CPSE:GMAB SWX:SENS and TSX:DCBO.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info